Cargando…
Dual‐hormone artificial pancreas for glucose control in type 1 diabetes: A meta‐analysis
AIM: To evaluate the efficacy and safety of a dual‐hormone artificial pancreas (DH) in type 1 diabetes. MATERIAL AND METHODS: PubMed, Embase, the Cochrane Library and ClinicalTrials.gov were searched for studies published up to February 16, 2022. We included randomized controlled trials that compare...
Autores principales: | Zeng, Baoqi, Jia, Hao, Gao, Le, Yang, Qingqing, Yu, Kai, Sun, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9542047/ https://www.ncbi.nlm.nih.gov/pubmed/35638377 http://dx.doi.org/10.1111/dom.14781 |
Ejemplares similares
-
Coming of age: the artificial pancreas for type 1 diabetes
por: Thabit, Hood, et al.
Publicado: (2016) -
Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis
por: Bekiari, Eleni, et al.
Publicado: (2018) -
Robust controller for artificial pancreas for patients with type-1 diabetes
por: Mandal, Sharmistha, et al.
Publicado: (2023) -
Investigation of the blood glucose target for mortality reduction by means of bedside-type artificial pancreas
por: Hoshino, M, et al.
Publicado: (2011) -
Fully Integrated Artificial Pancreas in Type 1 Diabetes: Modular Closed-Loop Glucose Control Maintains Near Normoglycemia
por: Breton, Marc, et al.
Publicado: (2012)